Evaluation of heterotopic bone formation induced by squalane and bone morphogenetic protein composite

被引:1
|
作者
Kawakami, T
Kawai, T
Takei, N
Kise, T
Eda, S
Urist, MR
机构
[1] AICHI GAKUIN UNIV,SCH DENT,DEPT DENT MAT SCI,NAGOYA,AICHI 464,JAPAN
[2] NEO DENT CHEM PROD CO,SHIOJIRI,JAPAN
[3] UNIV CALIF LOS ANGELES,SCH MED,BONE RES LAB,LOS ANGELES,CA 90024
关键词
D O I
暂无
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Bone morphogenetic protein is an important molecule whose bioactivity depends on the carrier, Squalane is used in the formulation of various kinds of cosmetics because it is easily emulsified and has the property of spreading well. Thus, squalane might be effective as a bone morphogenetic protein delivery system, As a test for this possibility, gelatin capsules containing squalane and bone morphogenetic protein (bovine derived partially purified) composite were implanted under the hindquarter perimuscular membrane of ddY mice, Control capsules containing only bone morphogenetic protein were used for controls, The implants were radiographically and histologically examined at 1 to 4 weeks after the operation, According to the radiographic analysis, squalane and bone morphogenetic protein composite and bone morphogenetic protein only control specimens formed widespread heterotopic bone tissues. The amount of heterotopic bone formation in the composite experimental specimens was approximately 40% greater than that in the controls. Histologic examination of experimental and control specimens revealed varying amounts of perichondral ossification by 2 weeks, By 3 and 4 weeks, the bone deposits were colonized by hematopoietic bone marrow, Squalane was effective for the slow local release of bone morphogenetic protein, Furthermore, the squalane and bone morphogenetic protein composite was a reliable osteoinductive biomaterial.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 50 条
  • [41] BONE MORPHOGENETIC PROTEIN
    URIST, MR
    STRATES, BS
    JOURNAL OF DENTAL RESEARCH, 1971, 50 (06) : 1392 - &
  • [42] Experimental Evaluation of Heterotopic Bone Formation with PET Radiopharmaceuticals
    Dannoon, Shorouk
    Alenezi, Saud
    Elgazzar, Abdelhamid
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [43] Bone morphogenetic protein
    Smoljanovic, Tomislav
    Bojanic, Ivan
    Cimic, Mislav
    JOURNAL OF NEUROSURGERY-SPINE, 2009, 11 (01) : 92 - 93
  • [44] Bone formation zones in heterotopic ossifications:: Histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors β2 and β3
    Toom, A.
    Arend, A.
    Gunnarsson, D.
    Ulfsparre, R.
    Suutre, S.
    Haviko, T.
    Selstam, G.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 (04) : 259 - 267
  • [45] PERIOSTEAL BONE-FORMATION ELICITED BY PARTIALLY PURIFIED BONE MORPHOGENETIC PROTEIN
    NAKAHARA, H
    TAKAOKA, K
    KOEZUKA, M
    SUGAMOTO, K
    TSUDA, T
    ONO, K
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1989, (239) : 299 - 305
  • [46] Can Bone Morphogenetic Protein Binding Peptide Increase Efficiency of Bone Formation?
    McGovern, Scott C.
    Fong, Winston
    Wang, Jeffrey C.
    SPINE, 2010, 35 (17) : 1655 - 1659
  • [47] Bone Formation Zones in Heterotopic Ossifications: Histologic Findings and Increased Expression of Bone Morphogenetic Protein 2 and Transforming Growth Factors ß2 and ß3
    A. Toom
    A. Arend
    D. Gunnarsson
    R. Ulfsparre
    S. Suutre
    T. Haviko
    G. Selstam
    Calcified Tissue International, 2007, 80 : 259 - 267
  • [48] Canola and hydrogenated soybean oils accelerate ectopic bone formation induced by implantation of bone morphogenetic protein in mice
    Hashimoto, Yoko
    Mori, Mayumi
    Kobayashi, Shuichiro
    Hanya, Akira
    Watanabe, Shin-Ichi
    Ohara, Naoki
    Noguchi, Toshihide
    Kawai, Tatsushi
    Okuyama, Harumi
    TOXICOLOGY REPORTS, 2014, 1 : 955 - 962
  • [49] Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model
    Honsawek S.
    Powers R.M.
    Wolfinbarger L.
    Cell and Tissue Banking, 2005, 6 (1) : 13 - 23
  • [50] Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline
    Horiuchi, H
    Saito, N
    Kinoshita, T
    Wakabayashi, S
    Tsutsumimoto, T
    Takaoka, K
    BONE, 2001, 28 (03) : 290 - 294